Latest News

Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today announced the appointment of Wayne Gombotz, PhD as Chief Technology Officer. Dr. Gombotz has more than 30 years’ experience in the biotech and pharma industries and most recently served as the Chief Development Officer at Immune Design. “We are pleased to welcome Wayne, a pi

Source link




Related posts

Scientists Use Gene Editing To Help HIV Patient Delete Disease In China

Newsemia

Sale of permanent birth control device to be discontinued due to risks

Newsemia

Tea Drinkers Have Healthier Cognitive Function

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy